Neoadjuvant chemotherapy followed by radical surgery in patients affected by FIGO stage IVA cervical cancer

Annals of Surgical Oncology

Volumn 14, Issue 9, 2007, Pages 2643-2648

  Benedetti Panici, Pierluigi ^a   Bellati, Filippo ^a   Manci, Natalina ^a   Pernice, Milena ^a   Plotti, Francesco ^a   Di Donato, Violante ^a   Calcagno, Marco ^a   Zullo, Marzio Angelo ^b   Muzii, Ludovico ^b   Angioli, Roberto ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY CAMPUS BIO MEDICO   (Italy)

Author keywords

Anterior pelvic exenteration; Cervical cancer; Neoadjuvant chemotherapy; Radical surgery

Indexed keywords

CISPLATIN; PACLITAXEL;

ADJUVANT THERAPY; ADULT; AGED; ALOPECIA; ANEMIA; ARTHRALGIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; CONTINUOUS INFUSION; CONTROLLED STUDY; DISEASE COURSE; FATIGUE; FEMALE; HUMAN; HYSTERECTOMY; INTRAOPERATIVE PERIOD; LYMPHADENECTOMY; MUCOSA INFLAMMATION; MYALGIA; NAUSEA; NEUTROPENIA; PERCEPTION DEAFNESS; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; TREATMENT OUTCOME; UTERINE CERVIX CANCER; VOMITING;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CISPLATIN; COMBINED MODALITY THERAPY; FEASIBILITY STUDIES; FEMALE; HUMANS; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; PACLITAXEL; SURVIVAL RATE; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 34548559534     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-007-9408-6     Document Type: Article

References (19)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55(2):74-108
2. Neoadjuvant, Chemotherapy for Cervical Cancer Meta-analysis Collaboration Neoadjuvant chemotherapy for locally advanced cervical cancer: a systematic review and meta-analysis of individual patient data from 21 randomised trials. Eur J Cancer 2003; 39(17):2470-86
3. Benedetti Panici P, Zullo MA, Muzii L, et al. The role of neoadjuvant chemotherapy followed by radical surgery in the treatment of locally advanced cervical cancer.Eur J Gynaecol Oncol 2003; 24: 467-70.
4. Sardi JE, Giaroli A, Sananes C, et al. Long-term follow-up of the first randomized trial using neoadjuvant chemotherapy in stage Ib squamous carcinoma of the cervix: the final results. Gynecol Oncol 1997; 67(1):61-9
5. Sardi J, Sananes CE, Giaroli A, et al. Neoadjuvant chemotherapy in cervical carcinoma stage IIB: a randomised controlled trial. Int J Gynecol Cancer 1998; 8:441-50
6. Sardi J, Giaroli A Sananes C, et al. Randomized trial with neoadjuvant chemotherapy in stage IIIB squamous carcinoma cervix uteri: an unexpected therapeutic management. Int J Gynecol Cancer 1996; 6:85-93
7. Benedetti-Panici P, Greggi S, Colombo A, et al. Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer: results from the Italian multicenter randomized study. J Clin Oncol 2002; 20(1):179-88
8. Hockel M, Dornhofer N. Pelvic exenteration for gynaecological tumours: achievements and unanswered questions. Lancet Oncol 2006 Oct; 7(10):837-47
9. Benedet JL, Odicino F, Maisonneuve P, et al. Carcinoma of the cervix uteri. J Epidemiol Biostat 2001; 6(1): 7-43
10. Bricker EM. Bladder substitution with isolated small intestine segments; a progress report. Am Surg 1952 July; 18(7):654-64
11. Whitney CW, Sause W, Bundy BN, et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol 1999; 17(5): 339-48
12. Morris M, Eifel PJ, Lu J, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 1999; 340(15): 137-43
13. Rose PG, Bundy BN, Watkins EB, et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 1999; 340(15):1144-53
14. Keys HM, Bundy BN, Stehman FB, et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 1999; 340(15):1154-61
15. Peters WA 3rd, Liu PY, Barrett RJ 2nd, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 2000; 18(8):1606-13
16. Thomas GM. Improved treatment for cervical cancer-concurrent chemotherapy and radiotherapy. N Engl J Med 1999; 340(15):1198-200
17. Dowdy SC, Boardman CH, Wilson TO, Podratz KC, Hartmann LC, Long HJ. Multimodal therapy including neoadjuvant methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) for stage IIB to IV cervical cancer. Am J Obstet Gynecol 2002; 186(6):1167-73
18. Souhami L, Gill RA, Allan SE, et al. A randomized trial of chemotherapy followed by pelvic radiation therapy in stage IIIB carcinoma of the cervix. J Clin Oncol 1991; 9(6):970-7
19. Park DC, Kim JH, Lew YO, Kim DH, Namkoong SE. Phase II trial of neoadjuvant paclitaxel and cisplatin in uterine cervical cancer. Gynecol Oncol 2004; 92(1):56-63